Enantiomers, Antibiotics May Benefit As Hatch Pushes Incentives In FDA Bill

Exclusivity and other incentives to encourage antibiotic development are among the details being negotiated by Senate Health, Education, Labor and Pensions Committee members as part of the FDA Revitalization Act